Pharmacovigilance_Market_will_Grow_at_a_CAGR_of_13%_by_2020_-_by_Market_Research_Engine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5) Comprehensive company pr<strong>of</strong>iles <strong>of</strong> major players in the industry.<br />
REPORT SCOPE:<br />
The scope <strong>of</strong> the report includes a detailed study <strong>of</strong> global and regional markets for various<br />
types <strong>of</strong> co<strong>at</strong>ings with the reasons given for vari<strong>at</strong>ions in the growth <strong>of</strong> the industry in<br />
certain regions.<br />
The report covers detailed competitive outlook including the market share and company<br />
pr<strong>of</strong>iles <strong>of</strong> the key participants oper<strong>at</strong>ing in the global market.<br />
Key players pr<strong>of</strong>iled in the report include:<br />
• Quintiles Transn<strong>at</strong>ional Corpor<strong>at</strong>ion<br />
• Accenture Plc.<br />
• Boehringer Ingelheim GmbH<br />
• Bristol-Myers Squibb<br />
• PAREXEL Intern<strong>at</strong>ional Corpor<strong>at</strong>ion<br />
• Janssen <strong>Research</strong> & Development LLC<br />
• Pharmaceutical Product Development Inc.<br />
• United BioSource Corpor<strong>at</strong>ion<br />
• Synowlwedge LLC<br />
• Cognizant Technology Solutions Corpor<strong>at</strong>ion<br />
• Covance Inc.<br />
• ICON, Plc.<br />
Company pr<strong>of</strong>ile includes assign such as company summary, financial summary, business<br />
str<strong>at</strong>egy and planning, SWOT analysis and current developments.<br />
The Top Companies Report is intended to provide our buyers with a snapshot <strong>of</strong> the<br />
industry’s most influential players.<br />
The <strong>Pharmacovigilance</strong> <strong>Market</strong> has been segmented as below:<br />
<strong>by</strong> Clinical Trial Phase<br />
• Pre clinical<br />
• Phase I<br />
• Phase II<br />
• Phase III<br />
• Phase IV<br />
<strong>by</strong> Type <strong>of</strong> Service Provider<br />
• In- House<br />
• Contract outsourcing<br />
<strong>by</strong> Region<br />
• North America<br />
• Europe<br />
• Asia Pacific<br />
• Rest <strong>of</strong> the World (RoW)<br />
Reasons to buy this Report:<br />
1) Obtains the most up to d<strong>at</strong>e inform<strong>at</strong>ion available on all active and planned<br />
pharmacovigilance industry globally.<br />
2) Identify growth segments and opportunities in the industry.<br />
3) Facilit<strong>at</strong>e decision making on the basis <strong>of</strong> strong historic and forecast <strong>of</strong><br />
pharmacovigilance industry and unit capacity d<strong>at</strong>a.<br />
4) Assess your competitor’s refining portfolio and its evolution.
Change language